BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24345070)

  • 1. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
    Burri E; Beglinger C
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):197-210. PubMed ID: 24345070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pediatrics. Fecal calprotectin in children: use and interpretation].
    Ezri J; Nydegger A
    Rev Med Suisse; 2011 Jan; 7(277):69-70. PubMed ID: 21309180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fecal calprotectin in gastrointestinal disorders.
    Montalto M; Gallo A; Santoro L; D'Onofrio F; Landolfi R; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1569-82. PubMed ID: 23832721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal markers: calprotectin and lactoferrin.
    Abraham BP; Kane S
    Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
    Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
    Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
    Bonnín Tomàs A; Vila Vidal M; Rosell Camps A
    Rev Esp Enferm Dig; 2007 Dec; 99(12):689-93. PubMed ID: 18290691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fecal calprotectin as a biomarker effectiveness of various interventions in patients with inflammatory bowel disease].
    Lazebnik LB; Guseĭn-Zade MG; Efremov LI; Sagynbaeva VÉ; Kniazev OV
    Eksp Klin Gastroenterol; 2013; (8):11-6. PubMed ID: 24933942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of fecal biomarkers in inflammatory bowel disease.
    Sutherland AD; Gearry RB; Frizelle FA
    Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
    Burri E; Manz M; Rothen C; Rossi L; Beglinger C; Lehmann FS
    Clin Chim Acta; 2013 Feb; 416():41-7. PubMed ID: 23178549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S; Shajib MS; Reinisch W; Khan WI
    J Gastroenterol; 2016 May; 51(5):434-46. PubMed ID: 26897740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C; David L; Portincasa P; Dumitraşcu DL
    Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases.
    Damms A; Bischoff SC
    Int J Colorectal Dis; 2008 Oct; 23(10):985-92. PubMed ID: 18629518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.